Main Street Capital's rising non-accruals indicate deteriorating fundamentals amidst high valuations. Read why profit-taking ...

Hims & Hers' future growth is expected from personalized solutions, with potential to expand the subscriber base by millions.

We advise caution on Dr. Martens due to risks and challenges. Read here for DOCMF stock's struggles post-IPO and potential ...

Toyota is a major player in R&D spend, especially in hybrid cars and solid-state battery technology, boasting over 1000 ...

Simpson Manufacturing's diverse market presence and innovation highlight its operational strengths. But read why SSD stock ...

Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.

WM Technology, Inc. lacks a competitive moat in the highly competitive software and IT industry, making it vulnerable to ...

EVgo's focus on DC fast charging and its asset-light eXtend segment drive impressive growth. Read why EVGO stock is a strong ...

Booking is the market leader in the online travel agency segment. Read why I plan to hold and potentially add to my BKNG ...

Pfizer terminated partnership with Sangamo on hemophilia A gene therapy despite positive Phase 3 data. Find out why SGMO ...

Strong Q4 results, stable 2025 guidance, and long-term projections reinforce ASML’s leadership. Read what makes ASML stock a ...

Read here for a discussion on semiconductor industry uncertainties from US-China trade tensions, AI competition, and ...